Similar articles

• An overview of Creutzfeldt-Jakob disease associated with the use of human pituitary growth hormone.

  Will RG. Will RG. Dev Biol Stand. 1991;75:85-6. Dev Biol Stand. 1991. PMID: 1794632 No abstract available.
• Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy.

  Fisman M. Fisman M. N Engl J Med. 1986 Apr 10;314(15):987-8. doi: 10.1056/NEJM198604103141511. N Engl J Med. 1986. PMID: 3515181 No abstract available.
• [Prions, Jakob-Creutzfeldt disease and human growth hormone].

  González PM. González PM. Rev Hosp Clin Fac Med Sao Paulo. 1986 Sep-Oct;41(5):207-9. Rev Hosp Clin Fac Med Sao Paulo. 1986. PMID: 3296112 Portuguese. No abstract available.
• [Hypophyseal growth hormone and Creutzfeldt-Jakob disease in The Netherlands. Ad hoc Commission Creutzfeldt-Jakob-disease of the Dutch Growth Foundation].

  Rikken B, Massa GG, Wit JM, van den Brande JL. Rikken B, et al. Ned Tijdschr Geneeskd. 1996 Jun 1;140(22):1163-5. Ned Tijdschr Geneeskd. 1996. PMID: 8692348 Review. Dutch. No abstract available.
• [Creutzfeldt-Jakob disease in 4 children treated with growth hormone].

  Billette de Villemeur T, Gourmelen M, Beauvais P, Rodriguez D, Vaudour G, Deslys JP, Dormont D, Richard P, Richardet JM. Billette de Villemeur T, et al. Rev Neurol (Paris). 1992;148(5):328-34. Rev Neurol (Paris). 1992. PMID: 1448646 Review. French.